181 related articles for article (PubMed ID: 36167459)
1. [Progress of NRF2 Signaling Pathway in Promoting Proliferation
of Non-small Cell Lung Cancer].
Fang Y; Zou X; Hu S; Ji L
Zhongguo Fei Ai Za Zhi; 2022 Oct; 25(10):735-741. PubMed ID: 36167459
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
[TBL] [Abstract][Full Text] [Related]
3. Emerging roles of Nrf2 signal in non-small cell lung cancer.
Tian Y; Liu Q; He X; Yuan X; Chen Y; Chu Q; Wu K
J Hematol Oncol; 2016 Feb; 9():14. PubMed ID: 26922479
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and clinicopathological significance of NRF2 expression in non-small cell lung cancer: A meta-analysis.
Wang Q; Xu L; Wang G; Chen L; Li C; Jiang X; Gao H; Yang B; Tian W
PLoS One; 2020; 15(11):e0241241. PubMed ID: 33186371
[TBL] [Abstract][Full Text] [Related]
5. Role of NRF2 in Lung Cancer.
Sánchez-Ortega M; Carrera AC; Garrido A
Cells; 2021 Jul; 10(8):. PubMed ID: 34440648
[TBL] [Abstract][Full Text] [Related]
6. Nrf2 promotes progression of non-small cell lung cancer through activating autophagy.
Wang J; Liu Z; Hu T; Han L; Yu S; Yao Y; Ruan Z; Tian T; Huang T; Wang M; Jing L; Nan K; Liang X
Cell Cycle; 2017 Jun; 16(11):1053-1062. PubMed ID: 28402166
[TBL] [Abstract][Full Text] [Related]
7. 5-Methylcytosine transferase NSUN2 drives NRF2-mediated ferroptosis resistance in non-small cell lung cancer.
Chen Y; Jiang Z; Zhang C; Zhang L; Chen H; Xiao N; Bai L; Liu H; Wan J
J Biol Chem; 2024 Apr; 300(4):106793. PubMed ID: 38403250
[TBL] [Abstract][Full Text] [Related]
8. PRDX5 as a novel binding partner in Nrf2-mediated NSCLC progression under oxidative stress.
Chen X; Cao X; Xiao W; Li B; Xue Q
Aging (Albany NY); 2020 Jan; 12(1):122-137. PubMed ID: 31899687
[TBL] [Abstract][Full Text] [Related]
9. E3 ligase TRIM15 facilitates non-small cell lung cancer progression through mediating Keap1-Nrf2 signaling pathway.
Liang M; Wang L; Sun Z; Chen X; Wang H; Qin L; Zhao W; Geng B
Cell Commun Signal; 2022 May; 20(1):62. PubMed ID: 35534896
[TBL] [Abstract][Full Text] [Related]
10. Keap1-Nrf2 Interaction Suppresses Cell Motility in Lung Adenocarcinomas by Targeting the S100P Protein.
Chien MH; Lee WJ; Hsieh FK; Li CF; Cheng TY; Wang MY; Chen JS; Chow JM; Jan YH; Hsiao M; Hua KT; Kuo ML
Clin Cancer Res; 2015 Oct; 21(20):4719-32. PubMed ID: 26078391
[TBL] [Abstract][Full Text] [Related]
11. Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathway.
Leone A; Roca MS; Ciardiello C; Terranova-Barberio M; Vitagliano C; Ciliberto G; Mancini R; Di Gennaro E; Bruzzese F; Budillon A
Free Radic Biol Med; 2015 Dec; 89():287-99. PubMed ID: 26409771
[TBL] [Abstract][Full Text] [Related]
12. Interplay of MKP-1 and Nrf2 drives tumor growth and drug resistance in non-small cell lung cancer.
Wang H; Liu K; Chi Z; Zhou X; Ren G; Zhou R; Li Y; Tang X; Wang XJ
Aging (Albany NY); 2019 Dec; 11(23):11329-11346. PubMed ID: 31811110
[TBL] [Abstract][Full Text] [Related]
13. Kaempferol inhibits Nrf2 signalling pathway via downregulation of Nrf2 mRNA and induces apoptosis in NSCLC cells.
Fouzder C; Mukhuty A; Kundu R
Arch Biochem Biophys; 2021 Jan; 697():108700. PubMed ID: 33271149
[TBL] [Abstract][Full Text] [Related]
14. Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non-Small Cell Lung Carcinoma.
Song S; Nguyen V; Schrank T; Mulvaney K; Walter V; Wei D; Orvis T; Desai N; Zhang J; Hayes DN; Zheng Y; Major MB; Weissman BE
Mol Cancer Res; 2020 Dec; 18(12):1777-1788. PubMed ID: 32855269
[TBL] [Abstract][Full Text] [Related]
15. Metformin Sensitizes Non-small Cell Lung Cancer Cells to an Epigallocatechin-3-Gallate (EGCG) Treatment by Suppressing the Nrf2/HO-1 Signaling Pathway.
Yu C; Jiao Y; Xue J; Zhang Q; Yang H; Xing L; Chen G; Wu J; Zhang S; Zhu W; Cao J
Int J Biol Sci; 2017; 13(12):1560-1569. PubMed ID: 29230104
[TBL] [Abstract][Full Text] [Related]
16. LAPTM4B is associated with poor prognosis in NSCLC and promotes the NRF2-mediated stress response pathway in lung cancer cells.
Maki Y; Fujimoto J; Lang W; Xu L; Behrens C; Wistuba II; Kadara H
Sci Rep; 2015 Sep; 5():13846. PubMed ID: 26343532
[TBL] [Abstract][Full Text] [Related]
17. Nrf2-heme oxygenase-1 axis in mucoepidermoid carcinoma of the lung: Antitumoral effects associated with down-regulation of matrix metalloproteinases.
Tertil M; Golda S; Skrzypek K; Florczyk U; Weglarczyk K; Kotlinowski J; Maleszewska M; Czauderna S; Pichon C; Kieda C; Jozkowicz A; Dulak J
Free Radic Biol Med; 2015 Dec; 89():147-57. PubMed ID: 26393425
[TBL] [Abstract][Full Text] [Related]
18. Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) in non-small cell lung cancer.
Zeng Z; Wang ZY; Li YK; Ye DM; Zeng J; Hu JL; Chen PF; Xiao J; Zou J; Li ZH
Life Sci; 2020 Aug; 254():117325. PubMed ID: 31954159
[TBL] [Abstract][Full Text] [Related]
19. Elevated peroxiredoxin 1, but not NF-E2-related factor 2, is an independent prognostic factor for disease recurrence and reduced survival in stage I non-small cell lung cancer.
Kim JH; Bogner PN; Ramnath N; Park Y; Yu J; Park YM
Clin Cancer Res; 2007 Jul; 13(13):3875-82. PubMed ID: 17606720
[TBL] [Abstract][Full Text] [Related]
20. Suppression of radiation-induced migration of non-small cell lung cancer through inhibition of Nrf2-Notch Axis.
Zhao Q; Mao A; Guo R; Zhang L; Yan J; Sun C; Tang J; Ye Y; Zhang Y; Zhang H
Oncotarget; 2017 May; 8(22):36603-36613. PubMed ID: 28402268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
